Jessica Rearden

Jessica Rearden, PhD, RN, currently serves as the Vice President of Clinical Science at Candid Therapeutics since July 2024. Prior to this role, Jessica held various positions at RayzeBio, including Senior Director of Clinical Science and Director of Clinical Science. Jessica's experience also includes positions as Associate Director of Clinical Science and Senior Clinical Scientist at QED Therapeutics, as well as Clinical Scientist at AbbVie. Jessica's academic background features a PhD from the University of Pennsylvania School of Nursing and a Master of Science from the same institution. Additionally, Jessica has a Bachelor of Science in Nursing from Cedar Crest College and has held roles as a Clinical Research Nurse at Vita Hematology Oncology and the University of Pennsylvania. Jessica's extensive experience spans clinical trials, research, and nursing in oncology.